Taylor Harris
Chief Executive Officer chez CUTERA, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Taylor C.
Harris is currently the President & Chief Executive Officer at Cutera, Inc. He is also a Director at Endologix LLC, an Independent Director at PROCEPT BioRobotics Corp., a Director at Omada Health, Inc., and the Chief Financial Officer at Synthego Corp.
Previously, Mr. Harris held positions as a Director at HealthCor Catalio Acquisition Corp., the Chief Financial Officer & Vice President at Thoratec Corp., and the Vice President-Healthcare Investment Banking at JPMorgan Chase & Co. He also worked as an Associate Analyst at JPMorgan Securities LLC, the Chief Financial Officer & Senior Vice President at ZELTIQ Aesthetics, Inc., and the Chief Financial Officer at MyoKardia, Inc.Mr. Harris obtained his undergraduate degree from The University of North Carolina at Chapel Hill in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2023 | 49 786 ( 0,10% ) | 2 M $ | 31/03/2024 | |
CUTERA, INC.
1,40% | 29/08/2023 | 279 336 ( 1,40% ) | 410 624 $ | 31/03/2024 |
Postes actifs de Taylor Harris
| Sociétés | Poste | Début |
|---|---|---|
| PROCEPT BIOROBOTICS CORPORATION | Director/Board Member | 17/12/2020 |
| ENDOLOGIX, INC. | Director/Board Member | - |
| CUTERA, INC. | Chief Executive Officer | 07/08/2023 |
Omada Health, Inc.
 Omada Health, Inc. Packaged SoftwareTechnology Services Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Synthego Corp. provides the game changing by integrating science, engineering and software. It designs and builds software and hardware solutions for building automated smart research facilities. The company was founded Michael Dabrowski and Paul Dabrowski in 2012 and is headquartered in Redwood City, CA. | Director of Finance/CFO | 01/09/2022 |
Anciens postes connus de Taylor Harris
| Sociétés | Poste | Fin |
|---|---|---|
| MYOKARDIA, INC. | Director of Finance/CFO | 01/11/2020 |
| ZELTIQ AESTHETICS INC | Director of Finance/CFO | 28/04/2017 |
| THORATEC CORPORATION | Director of Finance/CFO | 08/10/2015 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Analyst-Equity | 01/02/2010 |
| ░░░░░░░░ ░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Taylor Harris
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| CUTERA, INC. | Health Technology |
| PROCEPT BIOROBOTICS CORPORATION | Health Technology |
| Entreprise privées | 8 |
|---|---|
Thoratec Corp.
 Thoratec Corp. Medical SpecialtiesHealth Technology Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA. | Health Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Synthego Corp. provides the game changing by integrating science, engineering and software. It designs and builds software and hardware solutions for building automated smart research facilities. The company was founded Michael Dabrowski and Paul Dabrowski in 2012 and is headquartered in Redwood City, CA. | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Omada Health, Inc.
Omada Health, Inc. Packaged SoftwareTechnology Services Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in San Francisco, CA. | Technology Services |
HealthCor Catalio Acquisition Corp.
 HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance HealthCor Catalio Acquisition Corp. operates as a Cayman Islands exempted company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on November 18, 2020 and is headquartered in New York, NY. | Finance |
